  See all
 |
Articles: Clinical Pharmacology |
Patient preferences in the choice of anti-TNF therapies in rheumatoid arthritis. Results from a questionnaire survey (RIVIERA study)
Rheumatology, 11/20/09
Tumor necrosis factor inhibitors and lung disease: A paradox of efficacy and risk
Seminars in Arthritis and Rheumatism, 11/20/09
Prior Articles
Baseline glucocorticoid dose and bone mineral density response with teriparatide or alendronate therapy in patients with glucocorticoid-induced osteoporosis
Journal of Rheumatology, 11/19/09 Etanercept overcomes P-glycoprotein-induced drug resistance in lymphocytes of patients with intractable rheumatoid arthritis
Modern Rheumatology, 11/19/09 Effect of etanercept on serum levels of soluble cell adhesion molecules (sICAM-1, sVCAM-1, and sE-selectin) and vascular endothelial growth factor in patients with rheumatoid arthritis
Scandinavian Journal of Rheumatology, 11/19/09 A systematic comparison of combination DMARD therapy and tumour necrosis inhibitor therapy with methotrexate in patients with early rheumatoid arthritis
Rheumatology, 11/18/09 A novel composite endpoint to evaluate the gastrointestinal (GI) effects of nonsteroidal antiinflammatory drugs through the entire GI tract
Journal of Rheumatology, 11/18/09 Monitoring methotrexate toxicity in juvenile idiopathic arthritis
Journal of Rheumatology, 11/18/09 Update on the efficacy, safety, and adherence to treatment of full length parathyroid hormone, PTH (1-84), in the treatment of postmenopausal osteoporosis
International Journal of Women's Health, 11/18/09
Free full text
Anabolic androgenic steroid induced necrotising myopathy
Rheumatology International, 11/18/09 Costs and outcomes for patients with rheumatoid arthritis treated with biological drugs in Sweden: a model based on registry data
Scandinavian Journal of Rheumatology, 11/17/09 Diffuse alveolar hemorrhage as an unusual presentation of systemic lupus erythematosus
Rheumatology International, 11/17/09 Rapid and sustained improvements in health-related quality of life, fatigue, and other patient-reported outcomes in rheumatoid arthritis patients treated with certolizumab pegol plus methotrexate over 1 year: Results from the RAPID 1 randomized controlled trial
Arthritis Research & Therapy, 11/16/09
Free full text
Patients perceptions of drug information given by a rheumatology nurse: A phenomenographic study
Musculoskeletal Care, 11/13/09 The use of tumour necrosis factor alpha-blockers in daily routine. An Austrian consensus project
Clinical Rheumatology, 11/13/09 Influence of cytokine inhibitors on concentration and activity of MMP-1 and MMP-3 in disc herniation
Arthritis Research & Therapy, 11/12/09
Free full text
Initiation of rheumatoid arthritis treatments and the risk of serious infections
Rheumatology, 11/12/09 Repair of erosions occurs almost exclusively in damaged joints without swelling
Annals of Rheumatic Diseases, 11/12/09
Exclusive Author Commentary Development of antisynthetase syndrome in a patient with rheumatoid arthritis
Rheumatology International, 11/12/09 Adiponectin may contribute to synovitis and joint destruction in rheumatoid arthritis by stimulating vascular endothelial growth factor, matrix metalloproteinase-1, and matrix metalloproteinase-13 expression in fibroblast-like synoviocytes more than proinflammatory mediators
Arthritis Research & Therapy, 11/11/09
Free full text
|
|
Receive free subspecialty "5-minute updates" via email
|
|
Indexed Journals: Arthritis & Rheumatism, Annals of Rheumatic Diseases, Journal of Rheumatology
more...
|
250 Available Pages
|
|
